Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
We've worked with patients who have a genuine needle phobia that makes adherence a weekly struggle
About 43% of large employer plans cover GLP-1 medications
Common side effects of this medication include nausea, diarrhea, vomiting, and some abdominal pain
At the higher doses, results were very consistent: All participants lost at least 5% of their body weight Around 3 in 4 lost 15% or more With placebo, only around 1 in 4 lost 5% or more Phase 3 update (TRIUMPH-4, 68 weeks, topline results) In December 2025 , Eli Lilly shared early (topline) results from a larger phase 3 study (TRIUMPH-4)
Required for some insurance appeals and for claiming medical expense tax deductions with the Canada Revenue Agency
The type 1 insulin-like growth factor receptor pathway
US$ 21.24
US$ 25.22
US$ 23.78
US$ 24.43
US$ 25.02
